trending Market Intelligence /marketintelligence/en/news-insights/trending/1Hp_Vc_K07bV-iGT1hNCmg2 content esgSubNav
In This List

Universal Biosensors acquiring hemostasis reference lab business

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021

Blog

Post-webinar Q&A: Global Credit Risk Trends 2021 and Beyond

Blog

University Essentials: From Crisis to Resilience – Navigating Sustainable Recovery


Universal Biosensors acquiring hemostasis reference lab business

Universal Biosensors Inc. is acquiring Lifelabs LP's hemostasis reference laboratory business to meet increased production demand.

Universal Biosensors manufactures Siemens Healthcare Diagnostics' Xprecia Stride test strips to diagnose potential heart attack-inducing blood clots.

Universal Biosensors did not disclose the terms of the acquisition.